Literature DB >> 23846547

Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer.

Kento Takatori1, Kazuki Terashima, Rihito Yoshida, Aya Horai, Shinya Satake, Takayuki Ose, Naoto Kitajima, Yoshikazu Kinoshita, Yusuke Demizu, Nobukazu Fuwa.   

Abstract

BACKGROUND: Little is known about acute upper gastrointestinal (GI) complications associated with gemcitabine-concurrent proton radiotherapy (GPT) for inoperable pancreatic cancer. We investigated acute GI complications following GPT in patients with inoperable pancreatic cancer using small-bowel endoscopy.
METHODS: This prospective single center observational study was conducted at the Hyogo Ion Beam Medical Center from January 2010 to January 2012. Ninety-one patients who had clinically and medically inoperable pancreatic cancer treated by GPT were analyzed. Endoscopic examinations were performed before and after GPT to clarify the incidence rates of radiation-induced ulcers, GI hemorrhage, and GI perforation associated with GPT.
RESULTS: Post-treatment endoscopic examinations revealed that 45 (49.4 %) patients had radiation-induced ulcers in the stomach and duodenum. Of those, many ulcerative lesions were found in the lower stomach (51 %) and horizontal part of the duodenum (39 %), regardless of the primary tumor site in the pancreas. Neither GI hemorrhage, nor perforation, was found in post-treatment endoscopy examinations.
CONCLUSION: Approximately half of the patients treated with GPT for inoperable pancreatic cancer exhibited radiation-induced ulcers in the stomach and duodenum.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846547     DOI: 10.1007/s00535-013-0857-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis.

Authors:  Kazuki Terashima; Yusuke Demizu; Naoki Hashimoto; Dongcun Jin; Masayuki Mima; Osamu Fujii; Yasue Niwa; Kento Takatori; Naoto Kitajima; Sachiyo Sirakawa; Ku Yonson; Yoshio Hishikawa; Mitsuyuki Abe; Ryohei Sasaki; Kazuro Sugimura; Masao Murakami
Journal:  Radiother Oncol       Date:  2012-01-31       Impact factor: 6.280

Review 2.  Particle radiation therapy using proton and heavier ion beams.

Authors:  Daniela Schulz-Ertner; Hirohiko Tsujii
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

3.  Radiological use of fast protons.

Authors:  R R WILSON
Journal:  Radiology       Date:  1946-11       Impact factor: 11.105

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 5.  Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.

Authors:  Carlos Sostres; Carla J Gargallo; Maria T Arroyo; Angel Lanas
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-04       Impact factor: 3.043

6.  Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.

Authors:  S M de Lange; C J van Groeningen; O W M Meijer; M A Cuesta; J A Langendijk; J M G H van Riel; H M Pinedo; G J Peters; S Meijer; B J Slotman; G Giaccone
Journal:  Eur J Cancer       Date:  2002-06       Impact factor: 9.162

Review 7.  Late effects of radiation therapy on the gastrointestinal tract.

Authors:  L R Coia; R J Myerson; J E Tepper
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

Review 8.  Pancreatic cancer.

Authors:  Donghui Li; Keping Xie; Robert Wolff; James L Abbruzzese
Journal:  Lancet       Date:  2004-03-27       Impact factor: 79.321

9.  Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis.

Authors:  C R Hamilton; A Horwich; J M Bliss; M J Peckham
Journal:  Radiother Oncol       Date:  1987-10       Impact factor: 6.280

10.  Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer.

Authors:  Keiko Shibuya; Natsuo Oya; Takashi Fujii; Ryuichiro Doi; Akira Nakamura; Yukinori Matsuo; Michihide Mitsumori; Masahiro Hiraoka
Journal:  Am J Clin Oncol       Date:  2011-04       Impact factor: 2.339

View more
  13 in total

Review 1.  Proton beam therapy for gastrointestinal cancers: past, present, and future.

Authors:  Shahed N Badiyan; Christopher L Hallemeier; Steven H Lin; Matthew D Hall; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2018-10

2.  RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only).

Authors:  R Charles Nichols; Bradford S Hoppe
Journal:  J Gastrointest Oncol       Date:  2013-12

Review 3.  Proton beam therapy for tumors of the upper abdomen.

Authors:  Ann Raldow; James Lamb; Theodore Hong
Journal:  Br J Radiol       Date:  2019-08-23       Impact factor: 3.039

Review 4.  Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?

Authors:  Xin Zhang; He-Jing Huang; Dan Feng; De-Jun Yang; Chang-Ming Wang; Qing-Ping Cai
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 5.  Proton therapy for pancreatic cancer.

Authors:  Romaine C Nichols; Soon Huh; Zuofeng Li; Michael Rutenberg
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

6.  Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.

Authors:  Vivek Verma; Steven H Lin; Charles B Simone; Minesh P Mehta
Journal:  J Gastrointest Oncol       Date:  2016-08

7.  Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancers.

Authors:  Nobuyoshi Fukumitsu; Toshiyuki Okumura; Yuichi Hiroshima; Toshiki Ishida; Haruko Numajiri; Keiko Nemoto Murofushi; Kayoko Ohnishi; Teruhito Aihara; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai
Journal:  Jpn J Radiol       Date:  2018-05-10       Impact factor: 2.374

Review 8.  Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?

Authors:  Constantin Dreher; Daniel Habermehl; Oliver Jäkel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2017-12-27       Impact factor: 3.481

9.  Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach.

Authors:  Eugene J Koay; Alexander N Hanania; William A Hall; Cullen M Taniguchi; Neal Rebueno; Sten Myrehaug; Katharine L Aitken; Laura A Dawson; Christopher H Crane; Joseph M Herman; Beth Erickson
Journal:  Pract Radiat Oncol       Date:  2020-02-13

Review 10.  Who Will Benefit from Charged-Particle Therapy?

Authors:  Kyung Su Kim; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2021-06-21       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.